Global Cord Blood Corporation announced that it plans to release unaudited financial results for the third quarter and first nine months of fiscal year 2020 on Wednesday, March 11, 2020, after the market close.
Earnings Call Scheduled for 8:00 a.m. ET on March 12, 2020
HONG KONG, March 9, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financial results for the third quarter and first nine months of fiscal year 2020 on Wednesday, March 11, 2020, after the market close.
The Company will host a conference call at 8:00 a.m. ET on Thursday, March 12, 2020 to discuss its financial performance and give a brief overview of the Company’s recent developments, followed by a question and answer session. Interested parties can access the audio webcast through the Company’s IR website at http://ir.globalcordbloodcorp.com. A replay of the webcast will be accessible two hours after the conference call and available for seven days at the same URL as above. Listeners can also access the call by dialing 1-646-722-4977 or 1-855-824-5644, for US callers, or +852-3027-6500, for Hong Kong callers, access code: 66192143#.
Please dial in ten minutes prior to the conference call to ensure proper connection, and be prepared to provide your name and company name to the operator.
Supplemental financial information referenced in the conference call and the third quarter and first nine months of fiscal year 2020 earnings press release will be available at http://www.globalcordbloodcorp.com, in the section titled “Investor Center/Press Release”, after 4:16 p.m. ET on Wednesday, March 11, 2020, and in the Company’s Report on Form 6-K for the month of March 2020, available on the Securities and Exchange Commission’s website at www.sec.gov.
About Global Cord Blood Corporation
Global Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses. Global Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit the Company’s website at:
http://www.globalcordbloodcorp.com.
For more information, please contact:
Global Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@globalcordbloodcorp.com
ICR, Inc.
William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (+1) 646-405-5185
Email: william.zima@icrinc.com
View original content:http://www.prnewswire.com/news-releases/global-cord-blood-corporation-to-report-third-quarter-and-first-nine-months-fiscal-2020-financial-results-301019457.html
SOURCE Global Cord Blood Corporation
Company Codes: NYSE:CO
